Caricamento...
Tumor necrosis factor-mediated disposition of infliximab in ulcerative colitis patients
Ulcerative Colitis (UC) is an inflammatory bowel disease typically affecting the colon. Patients with active UC have elevated tumor necrosis factor (TNF) concentrations in serum and colonic tissue. Infliximab is a monoclonal antibody directed against TNF and binds with high affinity. Target-mediated...
Salvato in:
| Pubblicato in: | J Pharmacokinet Pharmacodyn |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer US
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6868113/ https://ncbi.nlm.nih.gov/pubmed/31489538 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10928-019-09652-5 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|